Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
1 clinical trials · Condition
◉ Watch Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
| Record | Firm | Date |
|---|---|---|
| Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy (NCT01456676) | Novartis Pharmaceuticals | 2012-01-01 |
Track Philadelphia Chromosome Positive Chronic Myelogenous Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.